Skip to main content

Advertisement

Table 3 Data from HNSCC patients' serum employed to isolate circulating immune complexes.

From: MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis

Sample Localization Stage Sex Age Differentiation MUC1 In CIC MUC1 in IHQ MUC1-CT in IHQ CIC levels (OD) MUC1 serum levels (U/mL)
1 Larynx I M 52 Poorly + - - 0.306 3.9
2 Larynx III M 64 Well + - - 0.371 1.4
3 Larynx III M 56 Moderately + - + 0.320 1.2
4 Larynx III M 70 Moderately + - + 0.229 0.9
5 Larynx IVA M 58 Poorly - - + 0.411 2.2
6 Larynx IVA M 53 Moderately - - + 0.312 1.7
7 Oral Cavity IVA M 55 Moderately - + + 0.322 4.7
8 Oral Cavity IVA F 29 Moderately + - + 0.258 1.7
9 Oral Cavity IVA M 68 Moderately + - + 0.323 1.1
10 Oral Cavity IVA M 55 Moderately - - - 0.477 0.6
11 Oral Cavity IVA M 49 Well - - + 0.403 0.7
12 Pharynx IVA M 56 Moderately - - - 0.497 5.3
13 Pharynx IVA M 65 Moderately + - + 0.335 1.9
14 Pharynx IVA M 38 Poorly + + + 0.231 1.8
15 Pharynx IVA M 72 Moderately - - - 0.473 0.4
16 Pharynx IVB M 61 Moderately - - + 0.349 1.5
Positive/Total or mean value      8/16 2/16 11/16 0.351 2.0
  1. Clinical data with immunohistochemical detection and serum determination of MUC1, anti-MUC1 Abs and circulating immune complexes are depicted.